Navalign LLC Sells 51 Shares of The Cigna Group (NYSE:CI)

Navalign LLC reduced its stake in The Cigna Group (NYSE:CI) by 1.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,574 shares of the health services provider’s stock after selling 51 shares during the period. Navalign LLC’s holdings in The Cigna Group were worth $1,370,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Avestar Capital LLC grew its holdings in The Cigna Group by 0.8% during the 3rd quarter. Avestar Capital LLC now owns 4,585 shares of the health services provider’s stock valued at $1,312,000 after buying an additional 35 shares in the last quarter. Eads & Heald Wealth Management grew its stake in The Cigna Group by 1.7% during the third quarter. Eads & Heald Wealth Management now owns 2,123 shares of the health services provider’s stock valued at $607,000 after acquiring an additional 35 shares in the last quarter. Linscomb & Williams Inc. increased its holdings in The Cigna Group by 0.3% during the 4th quarter. Linscomb & Williams Inc. now owns 10,877 shares of the health services provider’s stock worth $3,604,000 after acquiring an additional 36 shares during the period. Gray Wealth Management Inc. lifted its stake in The Cigna Group by 4.2% in the 2nd quarter. Gray Wealth Management Inc. now owns 890 shares of the health services provider’s stock worth $250,000 after purchasing an additional 36 shares in the last quarter. Finally, Wambolt & Associates LLC boosted its holdings in The Cigna Group by 1.4% in the 2nd quarter. Wambolt & Associates LLC now owns 2,536 shares of the health services provider’s stock valued at $712,000 after purchasing an additional 36 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on CI. Oppenheimer reaffirmed an “outperform” rating and issued a $360.00 price target on shares of The Cigna Group in a report on Wednesday, January 17th. Barclays assumed coverage on shares of The Cigna Group in a research report on Wednesday, March 6th. They set an “overweight” rating and a $393.00 target price for the company. Wells Fargo & Company increased their price target on shares of The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 6th. Sanford C. Bernstein raised shares of The Cigna Group from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $330.00 to $372.00 in a report on Thursday, January 4th. Finally, Deutsche Bank Aktiengesellschaft upgraded The Cigna Group from a “hold” rating to a “buy” rating and raised their price target for the company from $355.00 to $370.00 in a research report on Thursday, February 1st. Two investment analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $361.29.

Insiders Place Their Bets

In related news, insider Eric P. Palmer sold 1,017 shares of the company’s stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $335.26, for a total value of $340,959.42. Following the sale, the insider now owns 45,564 shares in the company, valued at approximately $15,275,786.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, insider Eric P. Palmer sold 1,017 shares of the stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $335.26, for a total transaction of $340,959.42. Following the sale, the insider now directly owns 45,564 shares of the company’s stock, valued at approximately $15,275,786.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the firm’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the sale, the senior vice president now directly owns 2,102 shares of the company’s stock, valued at approximately $694,668.96. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 114,144 shares of company stock worth $39,296,330. 0.60% of the stock is currently owned by company insiders.

The Cigna Group Trading Down 0.0 %

NYSE:CI traded down $0.15 during trading hours on Thursday, hitting $363.19. The company had a trading volume of 1,159,837 shares, compared to its average volume of 1,658,859. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.67 and a quick ratio of 0.67. The stock has a 50-day moving average price of $333.26 and a 200 day moving average price of $307.47. The company has a market capitalization of $106.18 billion, a PE ratio of 20.95, a price-to-earnings-growth ratio of 1.10 and a beta of 0.55. The Cigna Group has a 52 week low of $240.50 and a 52 week high of $365.71.

The Cigna Group (NYSE:CI) last issued its quarterly earnings data on Friday, February 2nd. The health services provider reported $6.79 EPS for the quarter, topping the consensus estimate of $6.54 by $0.25. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The business had revenue of $51.15 billion during the quarter, compared to analyst estimates of $48.91 billion. During the same period last year, the business posted $4.96 earnings per share. The Cigna Group’s quarterly revenue was up 11.8% compared to the same quarter last year. On average, equities research analysts predict that The Cigna Group will post 28.36 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 21st. Investors of record on Wednesday, March 6th were given a dividend of $1.40 per share. This is a boost from The Cigna Group’s previous quarterly dividend of $1.23. This represents a $5.60 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date was Tuesday, March 5th. The Cigna Group’s dividend payout ratio (DPR) is 32.20%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.